3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Venous Thromboembolism
1
Neoplasms
1
Embolism
1
Interventions
Surveys and Questionnaires
13
Blood Specimen Collection
13
Specimen Handling
10
Magnetic Resonance Spectroscopy
5
Surgical Procedures, Operative
4
Radiotherapy
4
Observation
4
Data Collection
4
ribociclib
3
darolutamide
3
Watchful Waiting
3
Standard of Care
3
Patient Reported Outcome Measures
3
Mental Status and Dementia Tests
3
Interviews as Topic
3
Immune Checkpoint Inhibitors
3
Hepatectomy
3
Breath Tests
3
Biopsy
3
trastuzumab deruxtecan
2
palbociclib
2
atezolizumab
2
X-Rays
2
Ultrasonography
2
Tomography, X-Ray Computed
2
Sulfonylurea Compounds
2
Restraint, Physical
2
Neoadjuvant Therapy
2
Methods
2
Mass Screening
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Rivaroxaban
×
30 days
×
Clear all
NCT04618913
2026-05-26
VICTORIE
Pfizer
Active not recruiting
1 enrolled